These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8618810)
1. [Does multiple use of a cuprophan dialyser influence levels of chromium and cadmium during hemodialysis in patients with chronic kidney failure?]. Małecka J; Grzeszczak W; Zukowska-Szczechowska E; Jendryczko A; Baczyński R Pol Arch Med Wewn; 1995 Dec; 94(6):482-7. PubMed ID: 8618810 [TBL] [Abstract][Full Text] [Related]
2. [Concentration of chromium in blood serum of patients with chronic renal failure]. Małecka J; Grzeszczak W; Zukowska-Szczechowska EA; Jendryczko A; Baczyński R Pol Arch Med Wewn; 1995 Jan; 93(1):25-31. PubMed ID: 7479215 [TBL] [Abstract][Full Text] [Related]
3. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure]. Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856 [TBL] [Abstract][Full Text] [Related]
4. [Levels of cadmium in serum of patients with chronic renal failure]. Małecka J; Grzeszczak W; Zukowska-Szczechowska E; Jendryczko A; Baczyński R Przegl Lek; 1994; 51(7):291-5. PubMed ID: 7871201 [TBL] [Abstract][Full Text] [Related]
5. [Level of total plasma carnitine in patients with chronic renal failure in the course of diabetes and other etiologies treated with hemodialysis]. Gumprecht J; Snit M; Zukowska-Szczechowska E; Grzeszczak W; Moczulski D; Jendryczko A Pol Arch Med Wewn; 1995 Nov; 94(5):403-9. PubMed ID: 8833937 [TBL] [Abstract][Full Text] [Related]
6. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications. Kadiri S; Kehinde Z; Arije A; Salako BL Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127 [TBL] [Abstract][Full Text] [Related]
7. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration. Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678 [TBL] [Abstract][Full Text] [Related]
8. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure]. Starzyk J; Bartelik S; Sarnecka S Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940 [TBL] [Abstract][Full Text] [Related]
9. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells. Linnenweber S; Lonnemann G Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027 [TBL] [Abstract][Full Text] [Related]
10. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets]. Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988 [TBL] [Abstract][Full Text] [Related]
11. Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes. Sulková S; Votruba T; Lapcík O; Válek A Int J Artif Organs; 1990 Jan; 13(1):22-5. PubMed ID: 2203684 [TBL] [Abstract][Full Text] [Related]
12. [Effect of prolonged hemodialysis therapy on activity of superoxide dismutase and glutathione peroxidase in erythrocytes and leukocytes of patients with chronic renal failure]. Grzeszczak W; Galwas B; Jendryczko A; Pachelski J; Zukowska-Szczechowska E Pol Arch Med Wewn; 1994 Mar; 91(3):167-75. PubMed ID: 8029123 [TBL] [Abstract][Full Text] [Related]
13. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure]. Starzyk J; Kowalski D Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416 [TBL] [Abstract][Full Text] [Related]
14. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane]. Pak K; Kobira S; Tomoyoshi T; Nishimura N Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143 [TBL] [Abstract][Full Text] [Related]
15. Myoglobin elimination in end stage kidney disease patients on renal replacement treatment. Stefanović V; Bogićević M; Mitić M Int J Artif Organs; 1993 Sep; 16(9):659-61. PubMed ID: 8294158 [TBL] [Abstract][Full Text] [Related]
16. [Influence of long-term hemodialysis on serum trace elements concentration in patients with chronic renal failure]. Kamińska-Galwa B; Grzeszczak W; Jedryczko A; Pachelski J Przegl Lek; 1994; 51(1):9-14. PubMed ID: 8209000 [TBL] [Abstract][Full Text] [Related]
17. [Level of zinc, copper, selenium and nickel in serum of patients treated for chronic renal failure with hemodialysis--influence of erythropoietin therapy]. Kamińska-Galwas B; Grzeszczak W; Jedryczko A; Pachelski J Pol Arch Med Wewn; 1993 May; 89(5):368-76. PubMed ID: 8367370 [TBL] [Abstract][Full Text] [Related]
18. Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: a prospective randomised multicentre trial. International Multicentre Study Group. Jörres A; Gahl GM; Dobis C; Polenakovic MH; Cakalaroski K; Rutkowski B; Kisielnicka E; Krieter DH; Rumpf KW; Guenther C; Gaus W; Hoegel J Lancet; 1999 Oct; 354(9187):1337-41. PubMed ID: 10533862 [TBL] [Abstract][Full Text] [Related]
19. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?]. Sulková S; Lapcík O; Votruba T Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936 [TBL] [Abstract][Full Text] [Related]
20. [Concentrations of acute phase proteins in serum during the first two hours of hemodialysis using cuprophane and cellulose acetate dialyzers in patients with chronic renal failure]. Starzyk J; Bartelik S Pol Arch Med Wewn; 1993 Aug; 90(2):127-33. PubMed ID: 7504251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]